Adrenomed creates Adrecizumab to decrease death rates from sepsis

[News]

The German corporation Adrenomed AG today announced its intentions to contribute to the reduction of mortality from sepsis and septic shock. Sepsis is an advanced systemic infection that travels via the blood stream to many of the body's vital organs, which can lead to death and disability.

More... (http://www.news-medical.net/news/20130103/Adrenomed-creates-Adrecizumab-to-decrease-death-rates-from-sepsis.aspx)